
- Pharmaceutical Commerce - January/February 2009
Generics acceptance among consumers has zoomed, says Harris Poll
Beneficiaries include mass-market discount stores; chains and independents are suffering
There’s little surprise in the fact that U.S. consumers are more comfortable with generic medications, since the healthcare establishment has been promoting them aggressively for years. Harris Interactive (Rochester, NY) ran a survey on this topic in 2006, and has just
However, another polling question muddles this trend. When asked specifically about taking advantage of the Wal-Mart or Target pharmacy programs ($4 for a 30-d supply of certain generics; Kmart and other discounters have similar programs, as do some chains) the picture changes. The percentage of “very likely” or “likely” to use the programs dropped from 50% in 2006 to 47% in 2008. The data might be indicative of a difference between those with insurance programs and those without; even though the percentage expressing a preference for discount-store programs dropped, the number who were “absolutely certain” that they would use the programs rose, from 13 to 16%.
Nevertheless, it is striking how much the public’s perception of generics’ value has changed. Only 4% of respondents (down from 9% in 2006) said that they would “always” buy brand-name prescription drugs over generics—which almost suggests that consumers are actively avoiding branded products when given a choice.
Articles in this issue
over 16 years ago
Closing The Circle On Patient Adherenceover 16 years ago
3PLs Rise in Forward-Thinking Supply Chain Modelsover 16 years ago
A Pitched Battle in Cardiovascular Drug Marketingover 16 years ago
Wyeth Loses Supreme Court Case Over 'Implied' Pre-Emptionover 16 years ago
Syringe Design Gets a Makeoverover 16 years ago
Refinements in Cold Chain Secondary Packagingover 16 years ago
Inmar Rebrands Reverse-Logistics and Related Business Unitsover 16 years ago
The Packaging Contribution to Patient Adherenceover 16 years ago
Moving the Dial on Patient AdherenceNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.